Greer Adds New Senior Research Scientist to Its Source Materials Division
Posted on: Tuesday, 11 September 2007, 12:00 CDT
Greer, a leading developer and provider of allergy immunotherapy products and allergenic source materials, is pleased to announce the addition of Rosa Codina , Ph.D., as a Senior Research scientist in its Source Materials division. Dr. Codina's responsibilities will include overseeing scientific research and providing technical support to customers. Greer's Source Materials unit is a global leader in providing companies with allergenic materials to help them successfully meet their project and research needs. These products range from pollens and molds, to others that are more rare or complex.
Prior to joining Greer, Dr. Codina was the principal scientist at SDII-Global Corporation in Tampa, Fla., and also served as an Affiliate Assistant Professor of Internal Medicine, Division of Allergy and Clinical Immunology, at the University of South Florida. Dr. Codina is a widely published author and from 1994-2002 directed the Environmental Allergen Research Laboratory, Division of Allergy and Clinical Immunology, at the University of South Florida College of Medicine. She is an accomplished researcher in the areas of allergen identification, allergen characterization, allergen avoidance measures and aerobiology.
"We are excited to have Dr. Codina join our growing scientific team within Greer's Source Materials division," says Robert Esch, Ph.D., Greer Executive Vice President of Research and Development. "With the growing demand for specialized allergenic source materials and Greer's increased focus on clinical research, Dr. Codina's specialization in clinical development, as well as the allergen field, will be invaluable."
Dr. Codina graduated with both a B.S. and M.S. from the University of Barcelona, Barcelona, Spain where she studied biology and zoology. In 1996, she received her Ph.D. from the University of Barcelona, with her doctoral thesis focused on aerobiology, allergen identification and serology. She completed her post-graduate work at the University of South Florida.
About Greer
Greer is a leading developer and provider of allergy immunotherapy products and services for treating humans and animals. Greer's highly skilled scientists provide technical support for customers by continuing to focus on improving the lives of allergic patients. Greer's clinical development programs are focused on expanding the use of immunotherapy through oral administration of allergy immunotherapy. Greer's goal is to establish the efficacy of standardized products for oral administration through clinical trials. The company was founded in 1904 and is located in Lenoir, N.C. For more information, visit www.greerlabs.com.
Source: Business Wire
Related Articles
- SOI Industry Consortium Reinforces its Academic and Research Support; Three More Prestigious Universities Join
- U.S. Concrete to Present at the Longbow Research Construction Materials Investor Conference
- Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
- IMUC Signs Research Agreement With George Mason University
- Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
- Universal Stainless to Present At Cleveland Research Specialty Materials Conference On May 10th
- NovaShunt AG, a Medical Device Company Focused on Implantable Fluid Management Systems, Appoints Fiona Sander, MSME, As Director of Research & Clinical Affairs
- Clinical Data and Duke University Collaborate on Cardio Studies
- Polyphasic Taxonomic Study of "Aeromonas Eucrenophila-Like" Isolates From Clinical and Environmental Sources
 |
 |
User Comments (0)
RSS Feeds